Routine versus selective functional testing after percutaneous coronary intervention in patients with diabetes mellitus

Journal of Invasive Cardiology

Volumn 17, Issue 1, 2005, Pages 25-29

  Saririan, Mehrdad ^a   Cugno, Sabrina ^a   Blankenship, James ^a   Huynh, Thao ^a   Sedlis, Steven ^a   Starling, Mark ^a   Pilote, Louise ^a   Wilson, Brooke ^a   Eisenberg, Mark J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; FOLLOW UP; FUNCTION TEST; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CHILD; CHILD, PRESCHOOL; CORONARY DISEASE; DEATH, SUDDEN, CARDIAC; DIABETES COMPLICATIONS; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PHYSICAL ENDURANCE; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 28444432708     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Kastrati A, Schomig A, Elezi S, et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol 1997;30:1428-1436.
2. Klugherz BD, DeAngelo DL, Kim BK, et al. Three-year clinical follow-up after Palmaz-Schatz stenting. J Am Coll Cardiol 1996;27:1185-1191.
3. Abizaid A, Kornowski R, Mintz GS, et al. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol 1998;32:584-589.
4. Elezi S, Kastrati A, Pache J, et al. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol 1998;32:1866-1873.
5. Weintraub WS, Kosinski AS, Brown CL, 3rd, King SB III. Can restenosis after coronary angioplasty be predicted from clinical variables? J Am Coll Cardiol 1993;21:6-14.
6. Holmes DR, Jr., Vlietstra RE, Smith HC, et al. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA Registry of the National Heart, Lung, and Blood Institute. Am J Cardiol 1984;53:77C-81C.
7. Vandormael M, Deligonul U, Taussig S, Kern MJ. Predictors of long-term cardiac survival in patients with multivessel coronary artery disease undergoing percutaneous transluminal coronary angioplasty. Am J Cardiol 1991;67:1-6.
8. Mick MJ, Piedmonte MR, Arnold AM, Simpfendorfer C. Risk stratification for long-term outcome after elective coronary angioplasty: A multivariate analysis of 5,000 patients. J Am Coll Cardiol 1994;24:74-80.
9. Stein B, Weintraub WS, Gebhart SP, et al. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation 1995;91:979-989.
10. Kip KE, Faxon DP, Detre KM, et al. Coronary angioplasty in diabetic patients: The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 1996;94:1818-1825.
11. Gibbons RJ, Balady GJ, Beasley JW, et al. ACC/AHA Guidelines for Exercise Testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol 1997;30:260-311.
12. Krone RJ, Hardison RM, Chaitman BR, et al. Risk stratification after successful coronary revascularization: The lack of a role for routine exercise testing. J Am Coll Cardiol 2001;38:136-142.
13. Hlatky MA, Boineau RE, Higginbotham MB, et al. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol 1989;64:651-654.
14. Spertus JA, Winder JA, Dewhurst TA, et al. Monitoring the quality of life in patients with coronary artery disease. Am J Cardiol 1994;74:1240-1244.
15. Ware JE, Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483.
16. Van Belle E, Bauters C, Hubert E, et al. Restenosis rates in diabetic patients: A comparison of coronary stenting and balloon angioplasty in native coronary vessels. Circulation 1997;96:1454-1460.
17. Bauters C, Hubert E, Prat A, et al. Predictors of restenosis after coronary stent implantation. J Am Coll Cardiol 1998;31:1291-1298.
18. Marso SP, Lincoff AM, Ellis SG, et al. Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: Results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy. Circulation 1999;100:2477-2484.
19. Bhatt DL, Marso SP, Lincoff AM, et al. Abciximab reduces mortality in diabetics following percutaneous coronary intervention. J Am Coll Cardiol 2000;35:922-928.
20. Kornowski R, Mintz GS, Kent KM, et al. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study. Circulation 1997;95:1366-1369.
21. Winocour PD, Richardson M, Kinlough-Rathbone RL. Continued platelet interaction with de-endothelialized aortae associated with slower re-endothelialization and more extensive intimal hyperplasia in spontaneously diabetic BB Wistar rats, Int J Exp Pathol 1993;74:603-613.
22. Winocour PD. Platelet abnormalities in diabetes mellitus. Diabetes 1992;41(Suppl 2):26-31.
23. Brooks MM, Jones RH, Bach RG, et al. Predictors of mortality and mortality from cardiac causes in the bypass angioplasty revascularization investigation (BARI) randomized trial and registry. For the BARI Investigators. Circulation 2000;101:2682-2689.
24. Bengtson JR, Mark DB, Honan MB, et al. Detection of restenosis after elective percutaneous transluminal coronary angioplasty using the exercise treadmill test. Am J Cardiol 1990;65:28-34.
25. Marie PY, Danchin N, Karcher G, et al. Usefulness of exercise SPECT-thallium to detect asymptomatic restenosis in patients who had angina before coronary angioplasty. Am Heart J 1993;126:571-577.
26. Sheppard R, Schechter D, Azoulay A, et al. Results of a routine exercise treadmill testing strategy early after percutaneous transluminal coronary angioplasty. Can J Cardiol 2001;17:407-414.
27. Manyari DE, Humen DP, Knudtson M. Sequential thallium-201 myocardial perfusion studies after successful percutaneous transluminal coronary artery angioplasty: Delayed resolution of exercise-induced scintigraphic abnormalities. Circulation 1988;1:86-95.